Vaccine Trials Seen Resuming; Cases Top 41 Million: Virus Update
A health worker inserts Covid-19 swab test tubes into a rack as students undergo testing in the central hall of Leuven University in Lueven, Belgium. (Photographer: Geert Vanden Wijngaert/Bloomberg)

Vaccine Trials Seen Resuming; Cases Top 41 Million: Virus Update

(Bloomberg) -- The U.S. trials of coronavirus vaccines made by AstraZeneca Plc and Johnson & Johnson may resume as soon as next week, according to the head of the Operation Warp Speed program. A pa...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.